Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment

Identifieur interne : 001504 ( Main/Exploration ); précédent : 001503; suivant : 001505

Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment

Auteurs : Chingching Foocharoen [Thaïlande] ; Ratanavadee Nanagara [Thaïlande] ; Siraphop Suwannaroj [Thaïlande] ; Ajanee Mahakkanukrauh [Thaïlande]

Source :

RBID : ISTEX:77F7F91D624C1F87B6EBA3776426190D67DD8666

English descriptors

Abstract

Background:  The major cause of death in systemic lupus erythematosus (SLE) is due to the disease activity itself or infection. It is uncertain whether the treatment approach during the last decade prolonged survival in SLE. Objective:  Our objective was to identify the causes of death and the factors predictive of mortality and to calculate the survival rate among SLE patients. Method:  We conducted a retrospective study of SLE patients followed up at Srinagarind Hospital, Khon Kaen University, Thailand, between January 1, 1996 and August 31, 2005. Cox regression analysis was used to estimate the probability of survival and assessing factors associated with death. The medical records of 749 SLE patients were reviewed; 66 patients died during the follow‐up period. Results:  The mortality rate was 1.2 per 100 person‐years. The 5‐ and 10‐year survival rate among our SLE patients was 93% and 87%, respectively. The mean age at death was 34.08 ± 11.75 years and the median disease duration was 48 (1–336) months. One‐third of the cases were referred from a local hospital more than 1 month after onset and were associated with a significantly higher risk of mortality than cases referred earlier (P = 0.047). The most common causes of death were opportunistic pulmonary infections and neuropsychiatric lupus. Factors predictive of mortality included: (i) major organ flare more than four times per year; (ii) age at onset > 50 years; (iii) high‐dose steroid use and/or immunosuppressive therapy at onset and within 2 weeks prior to death; and (iv) concomitant diabetes mellitus. Protective against mortality was antimalarial use.

Url:
DOI: 10.1111/j.1756-185X.2011.01639.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment</title>
<author>
<name sortKey="Foocharoen, Chingching" sort="Foocharoen, Chingching" uniqKey="Foocharoen C" first="Chingching" last="Foocharoen">Chingching Foocharoen</name>
</author>
<author>
<name sortKey="Nanagara, Ratanavadee" sort="Nanagara, Ratanavadee" uniqKey="Nanagara R" first="Ratanavadee" last="Nanagara">Ratanavadee Nanagara</name>
</author>
<author>
<name sortKey="Suwannaroj, Siraphop" sort="Suwannaroj, Siraphop" uniqKey="Suwannaroj S" first="Siraphop" last="Suwannaroj">Siraphop Suwannaroj</name>
</author>
<author>
<name sortKey="Mahakkanukrauh, Ajanee" sort="Mahakkanukrauh, Ajanee" uniqKey="Mahakkanukrauh A" first="Ajanee" last="Mahakkanukrauh">Ajanee Mahakkanukrauh</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:77F7F91D624C1F87B6EBA3776426190D67DD8666</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1111/j.1756-185X.2011.01639.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-JR87MWRR-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000302</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000302</idno>
<idno type="wicri:Area/Istex/Curation">000302</idno>
<idno type="wicri:Area/Istex/Checkpoint">000480</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000480</idno>
<idno type="wicri:doubleKey">1756-1841:2011:Foocharoen C:survival:rate:among</idno>
<idno type="wicri:Area/Main/Merge">001506</idno>
<idno type="wicri:Area/Main/Curation">001504</idno>
<idno type="wicri:Area/Main/Exploration">001504</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment</title>
<author>
<name sortKey="Foocharoen, Chingching" sort="Foocharoen, Chingching" uniqKey="Foocharoen C" first="Chingching" last="Foocharoen">Chingching Foocharoen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Division of Allergy‐Immunology‐Rheumatology, Department of Medicine, Khon Kaen University, Khon Kaen</wicri:regionArea>
<wicri:noRegion>Khon Kaen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nanagara, Ratanavadee" sort="Nanagara, Ratanavadee" uniqKey="Nanagara R" first="Ratanavadee" last="Nanagara">Ratanavadee Nanagara</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Division of Allergy‐Immunology‐Rheumatology, Department of Medicine, Khon Kaen University, Khon Kaen</wicri:regionArea>
<wicri:noRegion>Khon Kaen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Suwannaroj, Siraphop" sort="Suwannaroj, Siraphop" uniqKey="Suwannaroj S" first="Siraphop" last="Suwannaroj">Siraphop Suwannaroj</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Division of Allergy‐Immunology‐Rheumatology, Department of Medicine, Khon Kaen University, Khon Kaen</wicri:regionArea>
<wicri:noRegion>Khon Kaen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mahakkanukrauh, Ajanee" sort="Mahakkanukrauh, Ajanee" uniqKey="Mahakkanukrauh A" first="Ajanee" last="Mahakkanukrauh">Ajanee Mahakkanukrauh</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Division of Allergy‐Immunology‐Rheumatology, Department of Medicine, Khon Kaen University, Khon Kaen</wicri:regionArea>
<wicri:noRegion>Khon Kaen</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">International Journal of Rheumatic Diseases</title>
<title level="j" type="alt">INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES</title>
<idno type="ISSN">1756-1841</idno>
<idno type="eISSN">1756-185X</idno>
<imprint>
<biblScope unit="vol">14</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="353">353</biblScope>
<biblScope unit="page" to="360">360</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2011-10">2011-10</date>
</imprint>
<idno type="ISSN">1756-1841</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1756-1841</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Active disease</term>
<term>Aggressive treatment</term>
<term>Antimalarial</term>
<term>Antimalarial agents</term>
<term>Antimalarial drug</term>
<term>Arthritis rheum</term>
<term>Better care</term>
<term>Common cause</term>
<term>Concomitant diabetes mellitus</term>
<term>Diabetes mellitus</term>
<term>Disease activity</term>
<term>Disease duration</term>
<term>Erythematosus</term>
<term>Hazard ratio</term>
<term>Heart disease</term>
<term>Immunosuppressant</term>
<term>Immunosuppressive</term>
<term>Immunosuppressive agent</term>
<term>International journal</term>
<term>Intravenous methylprednisolone</term>
<term>Kaen</term>
<term>Khon</term>
<term>Khon kaen</term>
<term>Khon kaen university</term>
<term>Last decade</term>
<term>Local hospital</term>
<term>Local hospitals</term>
<term>Lupus</term>
<term>Lupus erythematosus patients</term>
<term>Lupus nephritis</term>
<term>Major cause</term>
<term>Major organ</term>
<term>Major organ involvement</term>
<term>Median survival time</term>
<term>Medical records</term>
<term>Mellitus</term>
<term>Mortality</term>
<term>Mortality risk</term>
<term>Multivariate analysis</term>
<term>Neuropsychiatric lupus</term>
<term>Odds ratio</term>
<term>Onset combination</term>
<term>Organ involvement</term>
<term>Previous reports</term>
<term>Prognosis factors</term>
<term>Prospective study</term>
<term>Pulmonary hemorrhage</term>
<term>Pulmonary involvement</term>
<term>Pulmonary involvements</term>
<term>Referral system</term>
<term>Regression analysis</term>
<term>Renal failure</term>
<term>Rheumatic</term>
<term>Rheumatic diseases</term>
<term>Skin involvements</term>
<term>Srinagarind hospital</term>
<term>Steroid</term>
<term>Steroid treatment</term>
<term>Survival curve</term>
<term>Survival rate</term>
<term>Survival rates</term>
<term>Systemic</term>
<term>Systemic lupus erythematosus</term>
<term>Thai</term>
<term>Thai patients</term>
<term>Univariate analysis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background:  The major cause of death in systemic lupus erythematosus (SLE) is due to the disease activity itself or infection. It is uncertain whether the treatment approach during the last decade prolonged survival in SLE. Objective:  Our objective was to identify the causes of death and the factors predictive of mortality and to calculate the survival rate among SLE patients. Method:  We conducted a retrospective study of SLE patients followed up at Srinagarind Hospital, Khon Kaen University, Thailand, between January 1, 1996 and August 31, 2005. Cox regression analysis was used to estimate the probability of survival and assessing factors associated with death. The medical records of 749 SLE patients were reviewed; 66 patients died during the follow‐up period. Results:  The mortality rate was 1.2 per 100 person‐years. The 5‐ and 10‐year survival rate among our SLE patients was 93% and 87%, respectively. The mean age at death was 34.08 ± 11.75 years and the median disease duration was 48 (1–336) months. One‐third of the cases were referred from a local hospital more than 1 month after onset and were associated with a significantly higher risk of mortality than cases referred earlier (P = 0.047). The most common causes of death were opportunistic pulmonary infections and neuropsychiatric lupus. Factors predictive of mortality included: (i) major organ flare more than four times per year; (ii) age at onset > 50 years; (iii) high‐dose steroid use and/or immunosuppressive therapy at onset and within 2 weeks prior to death; and (iv) concomitant diabetes mellitus. Protective against mortality was antimalarial use.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Thaïlande</li>
</country>
</list>
<tree>
<country name="Thaïlande">
<noRegion>
<name sortKey="Foocharoen, Chingching" sort="Foocharoen, Chingching" uniqKey="Foocharoen C" first="Chingching" last="Foocharoen">Chingching Foocharoen</name>
</noRegion>
<name sortKey="Mahakkanukrauh, Ajanee" sort="Mahakkanukrauh, Ajanee" uniqKey="Mahakkanukrauh A" first="Ajanee" last="Mahakkanukrauh">Ajanee Mahakkanukrauh</name>
<name sortKey="Nanagara, Ratanavadee" sort="Nanagara, Ratanavadee" uniqKey="Nanagara R" first="Ratanavadee" last="Nanagara">Ratanavadee Nanagara</name>
<name sortKey="Suwannaroj, Siraphop" sort="Suwannaroj, Siraphop" uniqKey="Suwannaroj S" first="Siraphop" last="Suwannaroj">Siraphop Suwannaroj</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001504 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001504 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:77F7F91D624C1F87B6EBA3776426190D67DD8666
   |texte=   Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021